Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Vir Biotechnology, Inc. (VIR) had Weighted-Average Shares Outstanding (Diluted) of 136.25M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$74.20M |
|
$-521.96M |
|
$0.84M |
|
$73.36M |
|
$661.37M |
|
$-587.16M |
|
$64.06M |
|
$-523.11M |
|
$-523.11M |
|
$-521.96M |
|
$-521.96M |
|
$-521.96M |
|
$-521.96M |
|
$-587.16M |
|
$-567.21M |
|
136.25M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
136.25M |
$-3.83 |
|
$-3.83 |
|
| Balance Sheet Financials | |
$1.04B |
|
$63.18M |
|
$356.36M |
|
$1.40B |
|
$119.66M |
|
-- |
|
$128.77M |
|
$248.43M |
|
$1.15B |
|
$1.13B |
|
$1.15B |
|
136.96M |
|
| Cash Flow Statement Financials | |
$-446.35M |
|
$499.37M |
|
$4.39M |
|
$261.29M |
|
$318.69M |
|
$57.40M |
|
$78.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.86% |
|
-791.27% |
|
-791.27% |
|
-764.38% |
|
-704.95% |
|
-703.40% |
|
$-450.28M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-45.37% |
|
-46.38% |
|
-37.31% |
|
-45.37% |
|
$8.40 |
|
$-3.30 |
|
$-3.28 |
|